Harte-hanks Inc (HHS) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

HHS ranks #8188 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

22 institutions disclose a position in HHS, but none treat it as a major bet — even Westerly Capital Management, LLC, its most concentrated holder, allocates just 0.3% of its own portfolio to it.

HHS reported a net loss of $5.7M over the trailing twelve months.

• Not yet profitable — net loss of $5.7M over the trailing twelve months
• Revenue declined 11.6% year over year
• Net income declined year over year, from -$3.0M to -$5.7M
• Operating cash flow was negative, using $1.7M in cash
• Current ratio of 1.54x — enough short-term assets to cover short-term liabilities
• Liabilities run 3.47x equity — a highly leveraged balance sheet worth noting